Fig. 4From: Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritisSynthesis and release of S100A11 by peripheral blood mononuclear cells (PBMCs) and synovial fibroblasts (SFs). PBMCs and SFs from patients with rheumatoid arthritis (RA) synthesize (a, b) and spontaneously release (c, d) higher levels of S100A11 compared to the cells from patients with osteoarthritis (OA). Representative images of protein levels of S100A11 in PBMCs and SFs isolated from patients with RA (n = 4) and patients with OA (n = 4) by western blotBack to article page